44 stories
All topics
At the ASCO 2026 conference, an international phase 3 trial showed the daily pill daraxonrasib roughly doubled survival in advanced pancreatic cancer — cracking a genetic target long considered “undruggable.”
After a three-wheeled electric bike was stolen from a woman with stage 4 breast cancer on Mother’s Day, Kansas City officer JP Young kept searching for a full month — and when he finally recovered it, local cyclists volunteered to repair it for free.
A peer-reviewed study in Nature (May 2026) describes Google DeepMind’s multi-agent “AI co-scientist,” built on Gemini, which generated hypotheses across three biomedical problems — including drug repurposing for acute myeloid leukemia that researchers then validated experimentally in the lab.
Gavi reported that HPV vaccination in lower-income countries has protected 86 million girls and is estimated to prevent 1.4 million cervical cancer deaths — with over a million already averted — reaching a major coverage target ahead of schedule.
Researchers at the University of Warwick discovered how bacterial enzymes use molecular “docking domains” to assemble anti-cancer compounds, opening the door to engineering new, more precise cancer therapies.
Described in Nature Cancer in April 2026, PRET — built by a team led by Prof. Li Xiaomeng at HKUST with Guangdong Provincial People’s Hospital and Harvard Medical School — brings “in-context learning” to pathology, recognizing 18 cancer types from just one to eight reference slides, with accuracy that matched or beat expert pathologists in key tasks.
A Mayo Clinic AI model called REDMOD, described in the journal Gut on April 30, 2026, found 73% of prediagnostic pancreatic cancers on routine CT scans a median of about 16 months before clinical diagnosis — nearly doubling detection and offering hope of catching one of the deadliest cancers while it is still treatable.
In a UK-led trial, colon cancer patients with a specific genetic subtype who received just nine weeks of the immunotherapy pembrolizumab before surgery have stayed cancer-free for nearly three years, with zero relapses so far.
In a São Paulo State University trial, 43% of women taking 2,000 IU vitamin D daily alongside neoadjuvant chemotherapy saw their breast cancer disappear, versus 24% on placebo — an inexpensive boost worth larger trials.
At the 2026 AACR meeting, Memorial Sloan Kettering researchers reported that a personalized mRNA pancreatic-cancer vaccine triggered immune responses lasting up to six years, with most responders still alive — a hopeful sign against one of the deadliest cancers.
Dying of cancer, Frank Ozimek’s final wish was to feed the hospice nurses who cared for him. When his brother called a local pizzeria, owner Tommy Milani shelved his Easter plans to make it happen.
On a Southwest Airlines flight, crew announced that 2-year-old passenger Cruz had beaten stage 4 neuroblastoma, prompting the entire cabin to erupt in cheers and write messages of encouragement on napkins.
Italian researchers used AI to design "Apt1," a novel molecule that disrupts DNA repair in pancreatic cancer cells, making tumors significantly more responsive to chemotherapy while sparing healthy cells.
Researchers at the University of Chicago developed an AI tool, published in Annals of Oncology, that classifies rare thymic epithelial tumors with high accuracy — helping non-expert pathologists diagnose 100% of aggressive thymic carcinomas in testing.
France has implemented a ban on PFAS — persistent "forever chemicals" linked to cancer and immune damage — in cosmetics, clothing, and ski wax, while mandating expanded drinking water testing.
Machine learning algorithms have successfully predicted the effectiveness of drug compounds for Alzheimer's and cancer, drastically compressing the traditionally years-long drug discovery process.
In a world first, researchers have used generative AI to design synthetic DNA molecules capable of controlling gene expression in healthy mammalian cells, opening new frontiers for precision cancer therapy.
Scientists have used AI to design smart DNA-based drugs that can identify and target cancer cells with extreme precision while leaving healthy cells untouched, potentially transforming cancer treatment by minimizing the devastating side effects of conventional chemotherapy.
Reports have highlighted Keanu Reeves' decades-long quiet philanthropy, revealing that the actor has donated tens of millions to cancer research through a private foundation — motivated by his sister's decade-long battle with leukemia — while deliberately keeping his name off the contributions.
Researchers at the University of Geneva developed MangroveGS, an AI model that predicts cancer metastasis and recurrence with nearly 80% accuracy. Trained on colon cancer, it works across stomach, lung, and breast cancer types.
The FDA approved Corcept Therapeutics' relacorilant (Lifyorli) on March 25, 2026, giving women with platinum-resistant ovarian cancer a new option that extended median survival to 16 months in a pivotal trial.
Two studies in Nature Cancer with Imperial College London and the NHS found that AI reviewing mammograms detected 25 percent of interval cancers humans had missed and could cut second-reader workload by about 40 percent.
Heman Bekele, a 14-year-old Ethiopian-American student from Virginia, was named TIME's 2023 Kid of the Year for developing an affordable soap-based skin cancer treatment that could provide accessible melanoma prevention in developing countries.
A major randomized trial in Sweden involving over 80,000 women found that AI-assisted mammography screening detected 20% more breast cancers than traditional double reading by two radiologists, while nearly halving radiologists' workload.
Researchers are using AI to predict someone's risk of over 1,000 different diseases before symptoms appear, including breast cancer — transforming medicine from reactive treatment to proactive prevention.
On 28 February 2026, India launched a free nationwide HPV vaccination campaign for 14-year-old girls, aiming to protect millions and sharply cut its heavy burden of cervical cancer.
Multiple studies confirm that AI-powered mammography screening can detect breast cancer up to 5 years before it becomes visible to human radiologists, with free open-source tools now being deployed in public hospitals worldwide.
Verified report based on cited source.
Verified report based on cited source.
A global trial led by Wake Forest, published in The Lancet Haematology in February 2026, found that ropeginterferon alfa-2b outperformed standard therapy for high-risk essential thrombocythemia patients who cannot tolerate hydroxyurea.
A major report reveals that cancer survival rates have doubled over the past 50 years, with experts declaring we are now in a 'golden age' for cancer research and treatment.
Two decades of dedicated cancer research have paid off: national survival rates have climbed to 70%, a remarkable achievement in the fight against the disease.
A French sailor who competed in the grueling Vendée Globe around-the-world race while battling cancer has been named Sailor of the Year for his extraordinary achievement.
A groundbreaking new therapy is offering hope to patients with blood cancers previously considered untreatable, showing remarkable results in clinical trials.
The American Cancer Society’s 2026 report found the five-year survival rate for all cancers combined has reached 70% for the first time, while cancer mortality has fallen 34% since 1991, averting 4.8 million deaths.
Reported in December 2025 in the New England Journal of Medicine, "off-the-shelf" base-edited CAR7 T cells drove very deep remissions in 82% of patients with resistant T-cell leukemia, with the earliest patients disease-free for three years.
GRAIL’s PATHFINDER 2 study, presented in October 2025, found that adding the Galleri multi-cancer blood test to routine screening increased the cancer detection rate more than seven-fold, with most cancers caught at earlier stages and a false-positive rate of just 0.4%.
Researchers developed new methods to detect pancreatic cancer earlier, potentially transforming survival rates for one of the deadliest cancers.
Researchers at the University of Florida developed an mRNA cancer vaccine that supercharges the immune system to recognize and attack cancer cells, paving the way for a potential universal cancer treatment.
Researchers at the University of Michigan are advancing histotripsy, a non-invasive technique that uses focused sound waves to mechanically destroy tumors without cutting into the body.
Cancer Research UK reports that survival rates have doubled over the past 50 years, with experts declaring a 'golden age' for cancer treatment and research.
Conservation group Aussie Ark announced in June 2025 that at least ten Tasmanian devil joeys had been born in its mainland breeding program, with more on the way. The births strengthen an “insurance population” safeguarding a species devastated by a contagious facial cancer.
For over two decades in Nanchang, China, Wan Zuocheng and Hong Gengxiang have run a tiny 'cancer kitchen' in an alley near a hospital, where families of patients can cook home-cooked meals for about 32 cents. Nearly 10,000 people now use it each year — a humble act of comfort and community.
Google DeepMind unveiled AlphaProteo, an AI that designs novel protein binders to grab targets like the SARS-CoV-2 spike and cancer-linked proteins, achieving 3-to-300-times better binding affinities than prior methods and an 88 percent success rate on one target.
